case_images: PMC3654325_01
case_images: PMC3654325_02
case_images: Dispersion of the anti-Toxocara IgG in serum samples of epileptic patients and healthy persons. Numbers in X-axis represent each sample (COP: cut-off point).
case_images: ERT2013-156815.001.jpg
case_images: PMC3654325_02_ERT2013-156815.001.jpg
case_images: fig1
case_images: The population seroprevalence of Toxocara antibodies was significantly higher in the epileptic patients compared with the healthy group (Figure 1).
case_images: Western blotting results for sera sample of the study population. Lane 1: reference ladder; lanes 2-4: sera testing positive by ELISA; Lane 5: Toxocara-negative control.
case_images: ERT2013-156815.002.jpg
case_images: PMC3654325_02_ERT2013-156815.002.jpg
case_images: fig2
case_images: The positive Western blotting strips indicating the presence of specific anti-Toxocara IgG in the samples showed at least two or more bands of lower molecular weight between 24 and 35 kDa (Figure 2).